Skip to content
10-Q

Quarterly Report

ALLOS THERAPEUTICS INC

0001104659-12-032343

← back to feed
Filed
May 3, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 1, 2012 106.96M sh
Operating Cash Flow Q1 2012 · Mar 31, 2012 −$4.27M
Operating Cash Flow Q1 2012 · Mar 31, 2011 −$19.07M
Cash And Equivalents Q1 2012 · Mar 31, 2012 $93.4M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $87.37M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $49.09M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $48.16M
Stockholders Equity Q1 2012 · Mar 31, 2012 $70.88M
Stockholders Equity Q1 2012 · Dec 31, 2011 $79.3M
Current Liabilities Q1 2012 · Mar 31, 2012 $20.01M
Current Liabilities Q1 2012 · Dec 31, 2011 $20.96M
Current Assets Q1 2012 · Mar 31, 2012 $106.5M
Current Assets Q1 2012 · Dec 31, 2011 $115.83M
Total Assets Q1 2012 · Mar 31, 2012 $112.42M
Total Assets Q1 2012 · Dec 31, 2011 $122.08M
Sga Expense Q1 2012 · Mar 31, 2012 $15.43M
Sga Expense Q1 2012 · Mar 31, 2011 $17.55M
Net Income Q1 2012 · Mar 31, 2012 −$11.32M
Net Income Q1 2012 · Mar 31, 2011 −$15.2M
Operating Income Q1 2012 · Mar 31, 2012 −$11.32M
Operating Income Q1 2012 · Mar 31, 2011 −$15.24M
Revenue Q1 2012 · Mar 31, 2012 $11.33M
Revenue Q1 2012 · Mar 31, 2011 $10.86M